Gloucester Pharmaceuticals Reports Positive Interim Phase II Data
on Romidepsin for T-Cell Lymphomas at the 2007 American Society of
Clinical Oncology Annual Meeting
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 5, 2007 - GloucesterPharmaceuticals, Inc., a privately held cancer therapeuticsdevelopment company, today announced that data for
romidepsin as atreatment for cutaneous T-cell lymphoma (CTCL) and peripheralT-cell lymphoma (PTCL) were presented at the American Society ofClinical Oncology (ASCO) Annual Meeting being held in Chicago, IL.The data presented...
Gloucester Pharmaceuticals Receives Fast Track Designation for
Romidepsin in Peripheral T-Cell Lymphoma
CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 16, 2007 - GloucesterPharmaceuticals, Inc., an oncology focused biopharmaceuticalcompany, announced today that the U.S. Food and Drug Administration(FDA) has granted Fast Track designation for its novel histonedeacetylase inhibitor,
romidepsin, for the monotherapy ofpreviously treated peripheral T-cell lymphoma (PTCL). The Companyhad previously announc...
Gloucester Pharmaceuticals Reports on Romidepsin and Erlotinib
Combination in Non-Small Cell Lung Cancer Presented at American
Association of Cancer Research Annual Meeting
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 18, 2007 - GloucesterPharmaceuticals, Inc., an oncology focused biopharmaceuticalcompany, announced today that encouraging data from a preclinicalstudy examining the combination of
romidepsin and erlotinib innon-small cell lung cancer (NSCLC) cell lines derived from humancancer patients were presented at the American Association ofCancer Research Meeti...
Gloucester Pharmaceuticals Announces Multiple Presentations of
Preclinical Romidepsin Data at American Association of Cancer
Research Annual Meeting
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 11, 2007 - GloucesterPharmaceuticals, Inc., an oncology focused biopharmaceuticalcompany, announced today that several abstracts coveringpreclinical work with
romidepsin will be presented at the 2007Annual Meeting of the American Association of Cancer Researchtaking place in Los Angeles, CA April 14-18, 2007. Thesepresentations will focus on a variety...